N. Murray

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Mechanisms of loss of HLA class I expression on colorectal tumor cells

Michael J. Browning, Fiorella Petronzelli, D C Bicknell et al. · Tissue Antigens · 1996 · 104 citations

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.

Ann B. Hill, S P Lee, John S. Haurum et al. · The Journal of Experimental Medicine · 1995 · 94 citations · Full text

Histocompatibility, Lymphoid Neoplasia, Autoimmune Disease +15

What proportion of patients with myocardial infarction are suitable for thrombolysis?

N. Murray, Jennifer Lyons, C Layton et al. · Heart · 1987 · 41 citations · Full text

Thrombosis, Trial Protocol 56, Heart Failure +13

Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes.

Koji Toshitani, Véronique M. Braud, Michael J. Browning et al. · Proceedings of the National Academy of Sciences · 1996 · 31 citations

Histocompatibility, Hla, Hla Immunogenetics +18